Posted inBusiness Insights
Eli Lilly’s Next-Generation Weight-Loss Drug Clears Critical Heart Safety Hurdle
Pharmaceutical giant Eli Lilly & Co. announced this week that its experimental, next-generation weight-loss therapy demonstrated no overall increase in cardiovascular risk in a major clinical evaluation, successfully clearing a…
